The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1016
December 19, 1997
View Complete Issue         Table of Contents 2019 
Quetiapine for Schizophrenia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Quetiapine for Schizophrenia
December 19, 1997 (Issue: 1016)
Quetiapine (Seroquel - Zeneca), a dibenzothiazepine derivative, has been approved by the FDA for treatment of schizophrenia and other psychotic disorders. It is a new addition to the 'atypical' antipsychotics, which include olanzapine (Zyprexa -...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Quetiapine for Schizophrenia
Article code: 1016a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.